Hua He

Dr. Hua He

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 January 2019 in Cardiovascular Diabetology
Verified
Journal Article
Open access
PDF file
ZQZheng Qin
Zheng Qin
KZKuo Zhou
Kuo Zhou
YLYue-Ping Li
Yue-Ping Li
JWJian-Long Wang
Jian-Long Wang
WCWan-Jun Cheng
Wan-Jun Cheng
YZYujie Zhou
Yujie Zhou
Increasing evidence has suggested that the presence of remnant lipoproteins is a significant risk factor for atherosclerosis. Remnant lipoproteins are lipoproteins that are rich in triglycerides (TGs), and the main components include very-low-density lipoprotein (VLDL) in the fasting state. Diabetic patients often have hypertriglyceridemia with elevated levels of VLDL cholesterol but normal levels of low-density lipoprotein cholesterol (LDL-C). The aim of the present study was to elucidate the potential role of remnant lipoproteins-induced atherosclerosis in the occurrence and development of in-stent restenosis (ISR) in diabetic patients with coronary artery disease. The present study enrolled 2312 patients with type 2 diabetes mellitus who underwent percutaneous coronary intervention from January 2013 to December 2014 and who were followed up by angiography. Patients were divided into two groups based on the presence or absence of ISR, and multivariate Cox’s proportional hazards regression modelling showed that remnant-like particle cholesterol (RLP-C) was an independent risk factor for ISR. According to the receiver operating characteristic curve, the optimal cutoff point of the RLP-C was identified, and the patients were further divided into 2 groups. Propensity score matching analysis was performed, and 762 pairs were successfully matched. Log-rank tests were used to compare Kaplan–Meier curves for overall follow-up to assess ISR. The multivariate Cox’s proportional hazards regression analysis showed that RLP-C was independently associated with ISR, and the baseline RLP-C level at 0.505 mmol/L was identified as the optimal cutoff point to predict ISR. Patients were divided into 2 groups by RLP levels. After propensity score matching analysis, a total of 762 pairs matched patients were generated. Kaplan–Meier curves showed that the estimated cumulative rate of ISR was significantly higher in patients with RLP-C levels ≥ 0.505 mmol/L (log-rank P < 0.001; HR equal to 4.175, 95% CI = 3.045–5.723, P < 0.001) compared to patients with RLP-C levels < 0.505 mmol/L. The present study emphasized the importance of remnant-like particle cholesterol in cardiovascular pathology in diabetic patients. Physicians should take measures to control RLP-C below the level of 0.505 mmol/L to better prevent of in-stent restenosis in diabetic patients.

30 September 2025 in Cardiovascular Diabetology
Verified
Journal Article
Open access
PDF file
LLLulu Liu
Lulu Liu
GYGuangzan Yu
Guangzan Yu
XJXuhou Ji
Xuhou Ji
YWYunlong Wang
Yunlong Wang
HHHua He
Hua He
Insulin resistance (IR)-related indices are increasingly recognized as important contributors to cardio-renal-metabolic (CRM) diseases. However, most prior studies have focused on isolated outcomes or cross-sectional disease status, lacking dynamic insight into disease progression. This study aimed to evaluate the predictive value of six IR-related indices for CRM onset and multistage progression using multistate modeling, and to explore potential biological mechanisms through mediation analysis. We included 327,692 CRM-free participants from the UK Biobank in this prospective cohort study. Six IR-related indices including triglyceride-glucose (TyG) index, TyG-body mass index (TyG-BMI), TyG-waist circumference (TyG-WC), TyG-waist-to-height ratio (TyG-WHtR), triglyceride/high-density lipoprotein cholesterol (TG/HDL-C) ratio, and metabolic score for insulin resistance (METS-IR), were calculated using established formulas. Cox proportional hazards and multistate models were used to assess associations with CRM incidence and progression. Predictive performance was evaluated using area under the curve (AUC), net reclassification improvement (NRI), and integrated discrimination improvement (IDI). Mediation analysis was conducted for inflammatory, hepatic, and renal biomarkers. Over a mean follow-up of 13.6 years, 17.3% (n = 58,563) of participants developed at least one CRM disease. All six IR-related indices were significantly associated with CRM multimorbidity, both in terms of incidence and progression. In predicting the incidence of CRM diseases, TyG-WC, TyG-WHtR, and METS-IR demonstrated superior performance. For each 1-standard deviation (SD) increase in TyG-WC, the risks of developing first, double, and triple CRM diseases increased by 51.4%, 88.6%, and 128.7%, respectively (all P < 0.001), with similar gradients observed for TyG-WHtR and METS-IR. Multistate Cox models further confirmed consistent associations between IR-related indices and CRM progression, particularly for TyG-WHtR and TyG. Specifically, a 1-SD increase in TyG-WHtR was associated with a 65.3% increased risk of transitioning from healthy to first CRM disease, 34.6% from first to double, and 26.7% from double to triple CRM diseases (all P < 0.001). In predictive performance evaluation, TyG-WC, TyG-WHtR, and METS-IR achieved the highest AUC, NRI, and IDI values. Mediation analyses indicated that systemic inflammation, organ function, and especially kidney function partially mediated the observed associations. In summary, IR-related indices, particularly TyG-WC, TyG-WHtR, and METS-IR, were observed to be associated with the presence and progression of CRM diseases. Their potential incorporation into risk assessment and prevention strategies, together with consideration of inflammatory and organ function pathways, might help reduce the burden of CRM multimorbidity; however, further prospective studies are needed to confirm these findings and clarify their clinical relevance.

23 July 2018 in Cell Death & Differentiation
Verified
Journal Article
Open access
PDF file
BKBingbing Ke
Bingbing Ke
YZYujie Zeng
Yujie Zeng
ZZZhihong Zhao
Zhihong Zhao
FHFusheng Han
Fusheng Han
TLTaoyan Liu
Taoyan Liu
HHHua He
Hua He
Congenital heart disease (CHD) is the most common cause of congenital anomaly and a leading cause of morbidity and mortality worldwide. Generation of cardiomyoctyes derived from pluripotent stem cells (PSCs) has opened new avenues for investigation of human cardiac development. Here we report that uric acid (UA), a physiologically abundant compound during embryonic development, can consistently and robustly enhance cardiac differentiation of human PSCs including hESCs and hiPSCs, in replacement of ascorbic acid (AA). We optimized treatment conditions and demonstrate that differentiation day 0–2, a period for specification of mesoderm cells, was a critical time for UA effects. This was further confirmed by UA-induced upregulation of mesodermal markers. Furthermore, we show that the developing mesoderm may be by directly promoted by SNAI pathway-mediated epithelial–mesenchymal transition (EMT) at 0–24 h and a lengthened G0/G1 phase by increasing the ubiquitination degradation in 24–48 h. These findings demonstrate that UA plays a critical role in mesoderm differentiation, and its level might be a useful indicator for CHD in early fetal ultrasound screening.

17 January 2018 in Journal of Thrombosis and Thrombolysis
Verified
Journal Article
Closed access
PDF file
HHHua He
Hua He
BKBingbing Ke
Bingbing Ke
YLYan Li
Yan Li
FHFuheng Han
Fuheng Han
XLXiaodong Li
Xiaodong Li
YZYujie Zeng
Yujie Zeng

5 August 2025 in European Journal of Medical Research
Verified
Journal Article
Open access
PDF file
LLLulu Liu
Lulu Liu
QMQian Ma
Qian Ma
GYGuangzan Yu
Guangzan Yu
XJXuhou Ji
Xuhou Ji
HHHua He
Hua He
Cardiac arrest (CA) is a critical condition with high mortality, despite advances in post-resuscitation care. Severe ischemia-reperfusion injury, systemic inflammation, nutritional status, and organ dysfunction contribute to poor prognosis, highlighting the need for reliable prognostic markers for early risk stratification. Lactate and albumin are well known to be involved in these pathological processes, making them potential biomarkers for prognostic assessment. This study aims to investigate the association between the lactate to albumin ratio (LAR) and all-cause mortality in patients with CA. Clinical data were collected from the MIMIC-IV (3.1) database. The individuals were categorized into four groups based on the quartiles of the LAR. The primary endpoint of the research was 30-day all-cause mortality, while the secondary endpoint was 90-day all-cause mortality. The association between the LAR and clinical outcomes was analyzed using Cox proportional hazards regression, restricted cubic splines, and Kaplan-Meier survival curves. Moreover, the predictive performance of the LAR for 30-day all-cause mortality in the CA population was evaluated using the Receiver Operating Characteristic (ROC) curve by calculating the Area Under the Curve (AUC). A total of 1311 patients with CA were enrolled in our study. After adjusting for confounders, each unit increase in the LAR was associated with a 20.1% and 19.6% increased risk of 30-day and 90-day all-cause mortality, respectively (P < 0.001), suggesting a possible nonlinear association. The Quartile 4 group exhibited a significantly higher mortality risk compared to the lowest quartile, when the LAR was treated as a categorical variable. Additionally, the ROC curve demonstrated moderate discriminatory ability of the LAR in recognizing 30-day all-cause mortality risk from the overall CA population (AUC: 0.69, 95% CI: 0.66–0.72), which was comparable to lactate but superior to albumin. The LAR exhibits a strong and nonlinear association with both 30-day and 90-day all-cause mortality, with elevated levels significantly increasing mortality risk, even after adjusting for potential confounders and applying multiple statistical methods. The ROC curve showed moderate discriminative ability, highlighting the potential of the LAR as a prognostic indicator in patients with CA.

30 April 2025 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Open access
RWRenjie Wang
Renjie Wang
LLLulu Liu
Lulu Liu
FHFusheng Han
Fusheng Han
QMQian Ma
Qian Ma
HHHua He
Hua He
Acute myocardial infarction (AMI) is the most common ischemic heart disease with high morbidity and high mortality. Although the treatment of AMI is constantly developing, ischemia-reperfusion (I/R) injury remains a complex problem. In recent years, human umbilical cord-derived mesenchymal stem cell-derived exosomes (hUC-MSC-EXO) have been shown to alleviate related damages. However, the long-term effects, safety, and mechanism of action have not yet been fully explored. We constructed human umbilical cord-derived mesenchymal stem cell-derived engineered exosomes. We compared the short-term and long-term protective abilities of engineered exosomes on myocardium during I/R in cardiomyocytes and rat models, and determined their long-term safety. At the same time, key pathways and genes were predicted through exosome sequencing. hUC-MSC-EXO significantly reduced apoptosis, oxidative stress, and inflammation in both in vitro and in vivo models. In I/R rats, IMTP-EXO demonstrated superior cardioprotective effects, reducing myocardial fibrosis and improving left ventricular function compared to controls. Long-term studies showed enhanced ejection fraction (EF) and fractional shortening (FS) and reduced left ventricular end-diastolic dimensions (LVEDD). Fluorescence imaging revealed higher exosome accumulation in ischemic hearts. Genes related to cardiovascular diseases were obtained through cross-comparison of multiple databases. GO analysis revealed that protein binding was the most highly enriched term. KEGG analysis showed that these genes were primarily involved in apoptosis and the PI3K-Akt signaling pathways. The PPI network showed that TP53, TLR4, EGFR, MAPK3, and GJA1 are central genes of heart I/R injury. GJA1, HMGB1, and PTEN are considered to be key genes by comparing to the comparative toxicogenomic database (CTD). This study demonstrates that hUC-MSC-derived exosomes, especially IMTP-EXO, are safe, feasible, and effective for reversing ventricular remodeling and improving cardiac function in rat MI models. GJA1, HMGB1, and PTEN may be the key genes associated with myocardial I/R injury. These findings provide critical insights for translating hUC-MSC-EXO into clinical applications for treating myocardial I/R injuries.